Farallon Capital Management as of Sept. 30, 2019
Portfolio Holdings for Farallon Capital Management
Farallon Capital Management holds 89 positions in its portfolio as reported in the September 2019 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Spdr S&p 500 Etf (SPY) | 10.1 | $981M | 3.3M | 296.77 | |
| Altaba | 6.8 | $666M | 34M | 19.48 | |
| Wabtec Corporation (WAB) | 4.6 | $451M | 6.3M | 71.86 | |
| Fidelity National Information Services (FIS) | 4.2 | $406M | 3.1M | 132.76 | |
| Iqvia Holdings (IQV) | 4.0 | $394M | 2.6M | 149.38 | |
| Alibaba Group Holding (BABA) | 3.7 | $364M | 2.2M | 167.23 | |
| IAC/InterActive | 3.3 | $318M | 1.5M | 217.97 | |
| Alphabet Inc Class C cs (GOOG) | 3.1 | $305M | 250k | 1219.00 | |
| Charter Communications Inc New Cl A cl a (CHTR) | 3.0 | $291M | 705k | 412.12 | |
| Anthem (ELV) | 2.6 | $255M | 1.1M | 240.10 | |
| Sherwin-Williams Company (SHW) | 2.5 | $247M | 450k | 549.87 | |
| Facebook Inc cl a (META) | 2.5 | $243M | 1.4M | 178.08 | |
| Playa Hotels & Resorts Nv (PLYA) | 2.5 | $240M | 31M | 7.83 | |
| Ihs Markit | 2.5 | $239M | 3.6M | 66.88 | |
| Visa (V) | 2.3 | $223M | 1.3M | 172.01 | |
| Equinix (EQIX) | 2.2 | $214M | 372k | 576.80 | |
| S&p Global (SPGI) | 2.1 | $204M | 832k | 244.98 | |
| Microsoft Corporation (MSFT) | 2.0 | $197M | 1.4M | 139.03 | |
| Citrix Systems | 1.9 | $183M | 1.9M | 96.52 | |
| General Dynamics Corporation (GD) | 1.9 | $181M | 992k | 182.73 | |
| Zayo Group Hldgs | 1.7 | $168M | 4.9M | 33.90 | |
| Cigna Corp (CI) | 1.6 | $161M | 1.1M | 151.79 | |
| Buckeye Partners | 1.6 | $160M | 3.9M | 41.09 | |
| Ascendis Pharma A S (ASND) | 1.5 | $149M | 1.6M | 96.32 | |
| Palo Alto Networks (PANW) | 1.3 | $124M | 610k | 203.83 | |
| Alnylam Pharmaceuticals (ALNY) | 1.2 | $121M | 1.5M | 80.42 | |
| Iovance Biotherapeutics (IOVA) | 1.1 | $110M | 6.0M | 18.20 | |
| AstraZeneca (AZN) | 1.1 | $106M | 2.4M | 44.57 | |
| Myokardia | 1.1 | $106M | 2.0M | 52.15 | |
| Sea Ltd Adr Isin Us81141r1005 (SE) | 1.1 | $105M | 3.4M | 30.95 | |
| Transunion (TRU) | 1.0 | $102M | 1.3M | 81.11 | |
| Acceleron Pharma | 1.0 | $95M | 2.4M | 39.51 | |
| Equifax (EFX) | 0.9 | $89M | 635k | 140.67 | |
| Alder Biopharmaceuticals | 0.8 | $79M | 4.2M | 18.86 | |
| Global Blood Therapeutics In | 0.8 | $78M | 1.6M | 48.52 | |
| Trinity Merger Corp | 0.8 | $77M | 75M | 1.03 | |
| Abbvie (ABBV) | 0.8 | $76M | 1.0M | 75.72 | |
| Enanta Pharmaceuticals (ENTA) | 0.8 | $77M | 1.3M | 60.08 | |
| Zogenix | 0.7 | $70M | 1.8M | 40.04 | |
| Grifols S A Sponsored Adr R (GRFS) | 0.6 | $62M | 3.1M | 20.04 | |
| Booking Holdings (BKNG) | 0.6 | $61M | 31k | 1962.62 | |
| CVS Caremark Corporation (CVS) | 0.6 | $57M | 900k | 63.07 | |
| Radius Health | 0.5 | $53M | 2.1M | 25.75 | |
| Sage Therapeutics (SAGE) | 0.5 | $52M | 373k | 140.29 | |
| Zymeworks | 0.4 | $43M | 1.7M | 24.80 | |
| Cara Therapeutics (CARA) | 0.4 | $39M | 2.2M | 18.28 | |
| Progenics Pharmaceuticals | 0.4 | $37M | 7.4M | 5.05 | |
| Fibrogen (FGEN) | 0.4 | $37M | 1.0M | 36.98 | |
| Nxp Semiconductors N V (NXPI) | 0.4 | $36M | 325k | 109.12 | |
| Fate Therapeutics (FATE) | 0.4 | $35M | 2.3M | 15.53 | |
| Ready Cap Corp Com reit (RC) | 0.4 | $35M | 2.2M | 15.92 | |
| Uber Technologies (UBER) | 0.3 | $34M | 1.1M | 30.47 | |
| Exelixis (EXEL) | 0.3 | $31M | 1.8M | 17.69 | |
| Amarin Corporation (AMRN) | 0.3 | $30M | 2.0M | 15.16 | |
| Invitae (NVTAQ) | 0.3 | $25M | 1.3M | 19.27 | |
| Ptc Therapeutics Inc conv bd us | 0.3 | $25M | 24M | 1.04 | |
| Deciphera Pharmaceuticals (DCPH) | 0.3 | $26M | 750k | 33.94 | |
| Zealand Pharma A/s- | 0.3 | $26M | 1.0M | 25.36 | |
| Symantec Corporation | 0.2 | $24M | 1.0M | 23.63 | |
| D Stemline Therapeutics | 0.2 | $24M | 2.3M | 10.41 | |
| Ptc Therapeutics I (PTCT) | 0.2 | $25M | 727k | 33.82 | |
| Veracyte (VCYT) | 0.2 | $24M | 1.0M | 24.00 | |
| Mirati Therapeutics | 0.2 | $23M | 300k | 77.91 | |
| Crispr Therapeutics (CRSP) | 0.2 | $23M | 560k | 40.99 | |
| Avrobio Ord (AVRO) | 0.2 | $22M | 1.6M | 14.12 | |
| Arrowhead Pharmaceuticals (ARWR) | 0.2 | $18M | 650k | 28.18 | |
| Solarcity Corp note 1.625%11/0 | 0.2 | $17M | 17M | 0.99 | |
| Protagonist Therapeutics (PTGX) | 0.2 | $18M | 1.5M | 12.01 | |
| Tricida | 0.2 | $15M | 500k | 30.87 | |
| Reata Pharmaceuticals Inc Cl A | 0.1 | $15M | 182k | 80.29 | |
| Chemocentryx | 0.1 | $14M | 2.0M | 6.78 | |
| Quotient | 0.1 | $13M | 1.7M | 7.77 | |
| ACADIA Pharmaceuticals (ACAD) | 0.1 | $13M | 350k | 35.99 | |
| Eiger Biopharmaceuticals | 0.1 | $12M | 1.1M | 10.25 | |
| Savara (SVRA) | 0.1 | $9.3M | 3.5M | 2.65 | |
| Axsome Therapeutics (AXSM) | 0.1 | $8.1M | 400k | 20.24 | |
| Clovis Oncology Inc note 1.250% 5/0 | 0.1 | $8.3M | 19M | 0.44 | |
| Exagen (XGN) | 0.1 | $5.6M | 363k | 15.49 | |
| Pfenex | 0.1 | $5.1M | 600k | 8.44 | |
| Cyclerion Therapeutics | 0.1 | $4.6M | 377k | 12.12 | |
| Sanofi Aventis Wi Conval Rt | 0.0 | $3.9M | 6.8M | 0.57 | |
| Uniqure Nv (QURE) | 0.0 | $4.0M | 101k | 39.36 | |
| Dermtech Ord ord (DMTK) | 0.0 | $3.4M | 615k | 5.60 | |
| Phasebio Pharmaceuticals (PHASQ) | 0.0 | $3.4M | 808k | 4.17 | |
| Ii-vi | 0.0 | $1.7M | 48k | 35.21 | |
| Aptinyx | 0.0 | $2.4M | 674k | 3.49 | |
| Gossamer Bio (GOSS) | 0.0 | $1.7M | 101k | 16.79 | |
| Zafgen | 0.0 | $1.3M | 1.8M | 0.74 | |
| Radius Health Inc note 3.000% 9/0 | 0.0 | $1.1M | 1.3M | 0.91 |
